Exact Mass: 377.1739328
Exact Mass Matches: 377.1739328
Found 123 metabolites which its exact mass value is equals to given mass value 377.1739328,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
7-[(3S,4S)-3-(Benzenesulfonamido)-2-bicyclo[2.2.1]heptanyl]hept-5-enoic acid
C20H27NO4S (377.1660702000001)
Sulfinalol
C20H27NO4S (377.1660702000001)
Talarozole
C21H23N5S (377.16740780000003)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist
(3E,6Z)-3-Benzylidene-6-[[4-[2-(dimethylamino)ethoxy]phenyl]methylidene]piperazine-2,5-dione
Ala Cys Gly Lys
Ala Cys Lys Gly
Ala Gly Cys Lys
Ala Gly Lys Cys
Ala Lys Cys Gly
Ala Lys Gly Cys
Cys Ala Gly Lys
Cys Ala Lys Gly
Cys Gly Ala Lys
Cys Gly Lys Ala
Cys Lys Ala Gly
Cys Lys Gly Ala
Gly Ala Cys Lys
Gly Ala Lys Cys
Gly Cys Ala Lys
Gly Cys Lys Ala
Gly Lys Ala Cys
Gly Lys Cys Ala
Lys Ala Cys Gly
Lys Ala Gly Cys
Lys Cys Ala Gly
Lys Cys Gly Ala
Lys Gly Ala Cys
Lys Gly Cys Ala
[4-(3-Methoxyphenyl)-1-piperazinyl](5-methyl-3-phenyl-1,2-oxazol- 4-yl)methanone
1,3,3-trimethyl-2-[(methyl-2-naphthylhydrazono)methyl]-3H-indolium chloride
C23H24ClN3 (377.16586540000003)
Urea, N-cyclopropyl-N-[(1,2-dihydro-6-methyl-2-oxo-3-quinolinyl)methyl]-N-(2-methoxyphenyl)- (9CI)
Tetrabutylammonium chlorochromate
C16H36ClCrNO3 (377.1788676000001)
3-Dibenzylamino-2-fluoropropionic acid, benzyl ester
dibutyl [[(diethylamino)thioxomethyl]thio]succinate
Methanone, [4-(4-methoxyphenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)-
Sulfinalol
C20H27NO4S (377.1660702000001)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
Propafenone hydrochloride
C21H28ClNO3 (377.17576080000003)
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Domitroban
C20H27NO4S (377.1660702000001)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
4-Hydroxy-7-isopropyl-6-oxo-n-(3-(1-piperidinyl)propyl)-6,7-dihydrothieno(2,3-b)pyridine-5-carboxamide
3-((4-(2-(Dimethylamino)ethoxy)phenyl)methylene)-6-(phenylmethylene)-2,5-piperazinedione
2-[2-Amino-5-(4-methoxyphenyl)-6-methylpyrimidin-4-yl]-5-[(2-methylprop-2-en-1-yl)oxy]phenol
5-benzoyl-6-methyl-4-[4-(4-morpholinyl)phenyl]-3,4-dihydro-1H-pyrimidin-2-one
Diethylaminoethyl diphenylhydroxypropionate hydrochloride
C21H28ClNO3 (377.17576080000003)
(3s)-1-(1,3-Benzodioxol-5-Ylmethyl)-3-[4-(1h-Imidazol-1-Yl)phenoxy]piperidine
2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
Talarozole
C21H23N5S (377.16740780000003)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist
2-[2-(1-Carboxyethylamino)ethylamino]-6-[(3-carboxy-3-hydroxypropanoyl)amino]hexanoic acid
Protuboxepin A
An organic heterotricyclic compound that is 10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione substituted by a benzyl group at position 8 and a butan-2-yl group at position 11. It has been isolated from Aspergillus species.
3-methoxy-N-[4-methyl-2-(4-morpholinyl)-6-quinolinyl]benzamide
3-[(2-fluorophenyl)methyl]-5-propyl-N-(pyridin-4-ylmethyl)-7-triazolo[4,5-d]pyrimidinamine
1-(2-Methoxyphenyl)-4-{[5-(4-methylphenyl)-3-isoxazolyl]carbonyl}piperazine
1-(3-Chlorophenyl)-3-(9-cyclopentyl-9-azabicyclo[3.3.1]nonan-3-yl)thiourea
C20H28ClN3S (377.1692358000001)
5-ethyl-3-[(2-fluorophenyl)methyl]-N-[2-(2-pyridinyl)ethyl]-7-triazolo[4,5-d]pyrimidinamine
N-methyl-N-(3-pyridinylmethyl)-5-(5,6,7,8-tetrahydronaphthalen-2-yloxymethyl)-3-isoxazolecarboxamide
(1R,5S)-N-(1,3-benzodioxol-5-yl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(1S,5R)-N-(1,3-benzodioxol-5-yl)-7-[4-[(E)-prop-1-enyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-prop-1-enyl]phenyl]-4-(pyridine-4-carbonyl)-1,4-diazabicyclo[4.2.0]octan-2-one
ethyl 2-[(4E)-4-[[4-(dimethylamino)phenyl]methylidene]-5-oxo-1-phenylpyrazol-3-yl]acetate
Co 101244 (hydrochloride)
C21H28ClNO3 (377.17576080000003)
Co 101244 (PD 174494) hydrochloride is a NR2B-containing NMDA receptor antagonist[1].
(1s,4r)-4-benzyl-3,10-dihydroxy-1-(sec-butyl)-1h,4h-pyrazino[2,1-b]quinazolin-6-one
(1r,4e,6s,7r,17s)-4-ethylidene-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate
C20H27NO6 (377.18382820000005)
n-{3-[(2e)-n-{4-[(hydroxymethylidene)amino]butyl}-3-phenylprop-2-enamido]propyl}methylsulfanylcarboximidic acid
(1r,1'r,5s,6'r)-5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclohexane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
C20H27NO6 (377.18382820000005)
4-ethylidene-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate
C20H27NO6 (377.18382820000005)
3-{2,4-dihydroxy-5-[(2e,4e)-n-(2-hydroxyethyl)-7-methylocta-2,4-dienamido]phenyl}propanoic acid
C20H27NO6 (377.18382820000005)
(1r,13s,14s,16r,19s)-10-carbamoyl-14-ethyl-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10,12(21)-pentaen-16-ium-16-olate
(1s,8s,10s,11r,12s,13s)-3,4,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-11,13-diol
C20H27NO6 (377.18382820000005)
(1r,13s,14s,19s)-10-carbamoyl-14-ethyl-9-oxo-8,16-diazahexacyclo[11.5.2.1¹,⁸.0²,⁷.0¹⁶,¹⁹.0¹²,²¹]henicosa-2,4,6,10,12(21)-pentaen-16-ium-16-olate
(1r,4e,6r,7r,17r)-4-ethylidene-6,7-dimethyl-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-7-yl acetate
C20H27NO6 (377.18382820000005)
methyl (1s,3r,4s,11s,13s,14e)-3,4-dimethoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate
C20H27NO6 (377.18382820000005)
(4s,7r)-7-benzyl-6-hydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
2-[2,6-dihydroxy-3,8-dimethylidene-4-(pyrrolidine-2-carbonyloxy)-octahydroazulen-5-yl]prop-2-enoic acid
C20H27NO6 (377.18382820000005)
4-benzyl-3,10-dihydroxy-1-(sec-butyl)-1h,4h-pyrazino[2,1-b]quinazolin-6-one
3,4,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-11,13-diol
C20H27NO6 (377.18382820000005)
(4r,7s)-7-benzyl-6-hydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
(1r,3s,5r,6s)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate
C20H27NO6 (377.18382820000005)
5-hydroxy-2',3',4-trimethoxy-10'-methyl-10'-azaspiro[cyclohexane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione
C20H27NO6 (377.18382820000005)
n-[3-(n-{4-[(hydroxymethylidene)amino]butyl}-3-phenylprop-2-enamido)propyl]methylsulfanylcarboximidic acid
7-benzyl-6-hydroxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1(10),2,5,11,13-pentaen-9-one
(1s,8s,10s,11r,12s,13s)-4,11,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-triene-3,13-diol
C20H27NO6 (377.18382820000005)
(2s)-6-[(3-carboxy-1,3-dihydroxypropylidene)amino]-2-({2-[(1-carboxyethyl)amino]ethyl}amino)hexanoic acid
6-[(3-carboxy-1,3-dihydroxypropylidene)amino]-2-({2-[(1-carboxyethyl)amino]ethyl}amino)hexanoic acid
2-[(2s,3ar,4r,5r,6s,8ar)-2,6-dihydroxy-3,8-dimethylidene-4-[(2s)-pyrrolidine-2-carbonyloxy]-octahydroazulen-5-yl]prop-2-enoic acid
C20H27NO6 (377.18382820000005)
3-{2,4-dihydroxy-5-[n-(2-hydroxyethyl)-7-methylocta-2,4-dienamido]phenyl}propanoic acid
C20H27NO6 (377.18382820000005)
methyl 3,4-dimethoxy-14-(2-methoxy-2-oxoethylidene)-9-azatetracyclo[7.5.0.0¹,⁶.0¹¹,¹³]tetradec-5-ene-13-carboxylate
C20H27NO6 (377.18382820000005)